Genetic and Molecular Toxicology

Genetic and molecular toxicology studies at Toxikon are conducted to elucidate molecular mechanisms involving clastogenicity, aneugenicity, DNA effects/frameshift, transverse and transition mutations, and carcinogenicity.

Genotoxicity evaluation constitutes an essential part of preclinical testing program for device and drug approval. A variety of genetic toxicology screening assays also play an important role in lead compound selection in the early phase of drug development. Our facilities and experienced laboratory management can offer the highest quality of work in compliance with ICH, OECD, ISO 17025 and many other globally-recognized standards. With decades of experience, our team will collaborate with you as an extension of your firm to facilitate drug and device development, achieve product safety and regulatory compliance, as well as maintain the highest levels of laboratory quality control.

Toxikon assay capabilities include, but are not limited to:

  • Bacterial mutation
  • Mammalian Cell
  • Mammalian Cytogenetics
  • Cell Transformation
  • DNA Damage/Repair


Click Image to download more information on Toxikon's Genetic and Molecular Toxicology capabilities.

Don't see what you are looking for? Submit the form below.
Genetic Toxicology Services | Preclinical Toxicology Testing Services | Genetic Toxicology | Molecular Toxicology | Toxicology Screening, Risk Assessment and Analysis
Preclinical Toxicology, Toxicological Analysis, Toxicology Risk Assessment, Toxicology Screening, Toxicology Testing Services, Preclinical Toxicology, Preclinical Toxicology Testing, Biochemical Toxicology, Molecular Toxicology
Toxikon provides specialized preclinical toxicology testing services (In Vivo and In Vitro) helping clients in biochemical and molecular toxicology screening, risk assessment and preclinical toxicology analysis for biotech, pharmaceutical and medical device sector.